[go: up one dir, main page]

UY30675A1 - Metodos para el tratamiento de la depresion - Google Patents

Metodos para el tratamiento de la depresion

Info

Publication number
UY30675A1
UY30675A1 UY30675A UY30675A UY30675A1 UY 30675 A1 UY30675 A1 UY 30675A1 UY 30675 A UY30675 A UY 30675A UY 30675 A UY30675 A UY 30675A UY 30675 A1 UY30675 A1 UY 30675A1
Authority
UY
Uruguay
Prior art keywords
treatment
depression
methods
formula
present
Prior art date
Application number
UY30675A
Other languages
English (en)
Inventor
Ewa Malatynska
Magali Haas
Robert Gordon
Yong Moon Choi
Original Assignee
Sk Holdings
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30675(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Holdings, Janssen Pharmaceutica Nv filed Critical Sk Holdings
Publication of UY30675A1 publication Critical patent/UY30675A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion consiste en un método para el tratamiento de la depresion, que comprende la administracion, a un sujeto que lo necesita, de una cantidad terapéutica eficaz de uno o más compuestos de carbamato de la Formula 1 o de la Formula 2, como se definen en esta solicitud, y como se exponen a continuacion, para el tratamiento de la depresion: La presente invencion se dirige a un método para el tratamiento de la depresion, que comprende el monotratamiento y alternativamente, el tratamiento conjunto con por lo menos un antidepresivo adicional.
UY30675A 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion UY30675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30

Publications (1)

Publication Number Publication Date
UY30675A1 true UY30675A1 (es) 2008-05-02

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30675A UY30675A1 (es) 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion

Country Status (22)

Country Link
US (1) US20080317883A1 (es)
EP (1) EP2081648A2 (es)
JP (1) JP2010508355A (es)
KR (1) KR20090110889A (es)
CN (1) CN101568362A (es)
AR (1) AR064241A1 (es)
AU (1) AU2007313865A1 (es)
BR (1) BRPI0718324A2 (es)
CA (1) CA2667949A1 (es)
CL (1) CL2007003120A1 (es)
EA (1) EA200970436A1 (es)
EC (1) ECSP099308A (es)
IL (1) IL198484A0 (es)
MX (1) MX2009004770A (es)
NI (1) NI200900073A (es)
NO (1) NO20092018L (es)
PE (1) PE20080929A1 (es)
SV (1) SV2009003247A (es)
TW (1) TW200835477A (es)
UY (1) UY30675A1 (es)
WO (1) WO2008055022A2 (es)
ZA (1) ZA200903771B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
BR112013013028B1 (pt) 2011-01-13 2021-02-09 Bio-Pharm Solutions Co., Ltd processo para a preparação de derivados de carbamato de fenila e composto
BR112014015482A8 (pt) 2011-12-27 2017-07-04 Bio Pharm Solutions Co Ltd compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
CN116478225B (zh) * 2023-04-12 2024-06-11 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
WO2002067925A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
RS50680B (sr) * 2001-02-27 2010-06-30 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
US6562867B2 (en) * 2001-02-27 2003-05-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
DE60216457T2 (de) * 2001-02-27 2007-09-20 Ortho-Mcneil Pharmaceutical, Inc. Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
CA2587481A1 (en) * 2004-10-28 2006-05-11 Sk Corporation Phenylalkylamino carbamates adjunctive therapy for depression

Also Published As

Publication number Publication date
CA2667949A1 (en) 2008-05-08
AR064241A1 (es) 2009-03-25
BRPI0718324A2 (pt) 2013-11-26
CL2007003120A1 (es) 2008-07-18
ZA200903771B (en) 2010-08-25
SV2009003247A (es) 2009-11-24
AU2007313865A1 (en) 2008-05-08
TW200835477A (en) 2008-09-01
CN101568362A (zh) 2009-10-28
WO2008055022A3 (en) 2008-06-19
IL198484A0 (en) 2011-08-01
US20080317883A1 (en) 2008-12-25
NO20092018L (no) 2009-05-26
NI200900073A (es) 2010-02-25
WO2008055022A2 (en) 2008-05-08
KR20090110889A (ko) 2009-10-23
EA200970436A1 (ru) 2009-12-30
JP2010508355A (ja) 2010-03-18
ECSP099308A (es) 2009-10-30
PE20080929A1 (es) 2008-07-19
MX2009004770A (es) 2009-08-17
EP2081648A2 (en) 2009-07-29

Similar Documents

Publication Publication Date Title
UY30675A1 (es) Metodos para el tratamiento de la depresion
CR10165A (es) "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión"
CR10748A (es) Compuesto de indol
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
GT200500213A (es) Composiciones fungicidas
DOP2012000128A (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
AR060089A1 (es) Tratamiento del dolor
EA201290919A1 (ru) Индазольные соединения и их применение
CR9753A (es) Agente terapeutico para diabetes
CR11292A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
GT200800138A (es) Combinacion de un inhibidor de acetilcolinesterasa y un agonista de 5-ht6 para el tratamiento de disfuncion cognitiva
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
DK2380584T3 (da) Immunstimulerende fremgangsmåde
MXPA06013039A (es) El tratamiento de enfermedad respiratoria.
CR10524A (es) Compuesto triciclico y uso farmaceutico del mismo
GT200500063A (es) Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
GT200500310A (es) Compuestos organicos
GT200500291A (es) Nuevos heterociclos